Ares Life Sciences
Europe, Geneve, Switzerland, Geneva
Description
Ares Life Sciences is a venture capital firm specializing in expansion and late stage investments.
Investor Profile
Ares Life Sciences has made 2 investments, with 0 in the past 12 months and 100% as lead.
Stage Focus
- Series G (50%)
- Post Ipo Equity (50%)
Country Focus
- United States (50%)
- Switzerland (50%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
